Le Lézard
Classified in: Science and technology, Business
Subject: ECO

CI GAM Opens the Market


TORONTO, Jan. 18, 2024 /PRNewswire/ - Jennifer Sinopoli, Executive Vice-President and Head of Distribution, CI Global Asset Management (CI GAM), along with members of the CI GAM team, joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (TSX), to open the market and celebrate the launch of the CI U.S. Enhanced Momentum Index ETF (TSX: CMOM) and the CI U.S. Enhanced Value Index ETF (TSX: CVLU).

CMOM and CVLU target the momentum and value factors using indexes newly developed by VettaFi, LLC.

CI GAM is Canada's fifth-largest ETF provider, with approximately $21 billion in ETF assets under management (as at December 31, 2023). CI GAM's ETF lineup consists of 88 ETFs and includes beta, smart beta, asset allocation, managed volatility, actively managed, liquid alternatives, digital assets, covered calls, cash management, ESG, and other thematic mandates.

CNW sponsored announcement. To learn more visit www.newswire.ca

SOURCE Toronto Stock Exchange


These press releases may also interest you

at 01:00
Brinc, a global leader in corporate innovation and venture acceleration has acquired Callmi, a MENA-centric mentorship platform that offers 1:1 video consultations with top-tier expertsCallmi will scale offerings to users and also be further...

at 00:23
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for May 17, 2024. OKX to...

16 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 16, 2024. OKX Launches Cryptopedia Season 18, Offering Users Up to...

16 mai 2024
Mr. Narongsak Jivakanun (Second from left), CEO of PTT Global Chemical Public Company Limited (GC) presided over the signing ceremony and extended his congratulations to Krungthai Bank and NatureWorks - a joint venture of GC and a leading...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Velan Inc. ("Velan" or the "Company"), a world-leading manufacturer of industrial valves, announced today its financial results for its fourth quarter and fiscal year ended February 29, 2024. All amounts are expressed in U.S. dollars unless...



News published on and distributed by: